Literature DB >> 2510157

Immunoglobulin double-isotype expression by trans-mRNA in a human immunoglobulin transgenic mouse.

A Shimizu1, M C Nussenzweig, T R Mizuta, P Leder, T Honjo.   

Abstract

We have studied immunoglobulin double-isotype expression in a transgenic mouse (TG.SA) in which expression of the endogenous immunoglobulin heavy chain locus is almost completely excluded by a nonallelic rearranged human mu transgene. By flow-cytometric analyses, we have shown that a small, but significant, portion (about 4%) of transgenic spleen cells expresses human mu (transgene) and mouse gamma (endogenous) chains when cultured in vitro with bacterial lipopolysaccharide and interleukin 4. By using amplification of cDNA by the polymerase chain reaction, followed by cloning and sequencing of the amplified cDNA fragment, we have demonstrated expression of trans-mRNA consisting of the transgenic variable and endogenous constant (gamma 1) region sequences. Such trans-mRNA could be produced by either switch recombination or trans-splicing between the transgene and endogenous sterile gamma 1-gene transcripts. These results indicate that trans-splicing might be a possible mechanism for the immunoglobulin double-isotype expression in normal B lymphocytes that have not rearranged the second expressed constant region gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510157      PMCID: PMC298205          DOI: 10.1073/pnas.86.20.8020

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  T cell receptor gene trans-rearrangements: chimeric gamma-delta genes in normal lymphoid tissues.

Authors:  B Tycko; J D Palmer; J Sklar
Journal:  Science       Date:  1989-09-15       Impact factor: 47.728

2.  Recombinant IgG molecules in rabbits doubly heterozygous for group a and group e allotypic specificities.

Authors:  S L Tosi; R M Tosi
Journal:  Immunochemistry       Date:  1973-02

3.  CH gene rearrangements in IgM-bearing B cells and in the normal splenic DNA component of hybridomas making different isotypes of antibody.

Authors:  J L Hurwitz; C Coleclough; J J Cebra
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression.

Authors:  S Cory; J Jackson; J M Adams
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

5.  Synthesis of multiple immunoglobulin classes by single lymphocytes.

Authors:  B Pernis; L Forni; A L Luzzati
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

6.  Recombinant rabbit secretory immunoglobulin molecules: alpha chains with maternal (paternal) variable-region allotypes and paternal (maternal) constant-region allotypes.

Authors:  K L Knight; T R Malek; W C Hanly
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Deletion of immunoglobulin heavy chain genes from expressed allelic chromosome.

Authors:  Y Yaoita; T Honjo
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.

Authors:  J C Unkeless
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  17 in total

1.  Structure and expression of mouse germline immunoglobulin gamma 3 heavy chain transcripts induced by the mitogen lipopolysaccharide.

Authors:  S Gerondakis; C Gaff; D J Goodman; R J Grumont
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Short homologous sequences are strongly associated with the generation of chimeric RNAs in eukaryotes.

Authors:  Xin Li; Li Zhao; Huifeng Jiang; Wen Wang
Journal:  J Mol Evol       Date:  2008-12-17       Impact factor: 2.395

3.  The 5' and 3' splice sites come together via a three dimensional diffusion mechanism.

Authors:  Z Pasman; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

4.  Enhancer-dependent interaction between 5' and 3' splice sites in trans.

Authors:  J P Bruzik; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

5.  Germ-line human epsilon heavy chain gene RNA transcripts utilize the full range of alternative 3' splicing seen in productive epsilon mRNA.

Authors:  K Zhang; D Diaz-Sanchez; A Saxon
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

6.  Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germ line epsilon transcripts.

Authors:  P Rothman; S C Li; B Gorham; L Glimcher; F Alt; M Boothby
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

7.  Chromosomal position of rearranging gene segments influences allelic exclusion in transgenic mice.

Authors:  T E Costa; H Suh; M C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Replacement of germ-line epsilon promoter by gene targeting alters control of immunoglobulin heavy chain class switching.

Authors:  L Xu; B Gorham; S C Li; A Bottaro; F W Alt; P Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch.

Authors:  M Laffan; L Luzzatto
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 10.  Analysis of the immune system with transgenic mice: B cell development and lymphokines.

Authors:  A Iglesias
Journal:  Experientia       Date:  1991-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.